Elena Garreta

Elena Garreta

Auto-generated profile, based on publicly available information

Elena Garreta

Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2008 in Nature Biotechnology
Verified
Journal Article
Closed access
Trond AasenTrond Aasen
Trond Aasen
Angel RayaAngel Raya
Angel Raya
MBMaria J. Barrero
Maria J. Barrero
EGElena Garreta
Elena Garreta
ACAntonella Consiglio
Antonella Consiglio
JBJuan Carlos Izpisúa Belmonte
Juan Carlos Izpisúa Belmonte

31 May 2009 in Nature
Verified
Journal Article
Open access
PDF file
Angel RayaAngel Raya
Angel Raya
IRIgnasi Rodríguez-Pizà
Ignasi Rodríguez-Pizà
GGGuillermo Guenechea
Guillermo Guenechea
RVRita Vassena
Rita Vassena
SNSusana Navarro
Susana Navarro
Juan Carlos Izpisua BelmonteJuan Carlos Izpisua Belmonte
Juan Carlos Izpisua Belmonte
The generation of induced pluripotent stem (iPS) cells has enabled the derivation of patient-specific pluripotent cells and provided valuable experimental platforms to model human disease. Patient-specific iPS cells are also thought to hold great therapeutic potential, although direct evidence for this is still lacking. Here we show that, on correction of the genetic defect, somatic cells from Fanconi anaemia patients can be reprogrammed to pluripotency to generate patient-specific iPS cells. These cell lines appear indistinguishable from human embryonic stem cells and iPS cells from healthy individuals. Most importantly, we show that corrected Fanconi-anaemia-specific iPS cells can give rise to haematopoietic progenitors of the myeloid and erythroid lineages that are phenotypically normal, that is, disease-free. These data offer proof-of-concept that iPS cell technology can be used for the generation of disease-corrected, patient-specific cells with potential value for cell therapy applications.

31 October 2018 in Nature
Verified
Journal Article
Open access
PDF file
ELErnest Latorre
Ernest Latorre
SKSohan Sudhir Kale
Sohan Sudhir Kale
LCLaura Casares
Laura Casares
MGManuel Gómez-González
Manuel Gómez-González
MUMarina Uroz
Marina Uroz
XTXavier Trepat
Xavier Trepat
Fundamental biological processes are carried out by curved epithelial sheets that enclose a pressurized lumen. How these sheets develop and withstand three-dimensional deformations has remained unclear. Here we combine measurements of epithelial tension and shape with theoretical modelling to show that epithelial sheets are active superelastic materials. We produce arrays of epithelial domes with controlled geometry. Quantification of luminal pressure and epithelial tension reveals a tensional plateau over several-fold areal strains. These extreme strains in the tissue are accommodated by highly heterogeneous strains at a cellular level, in seeming contradiction to the measured tensional uniformity. This phenomenon is reminiscent of superelasticity, a behaviour that is generally attributed to microscopic material instabilities in metal alloys. We show that in epithelial cells this instability is triggered by a stretch-induced dilution of the actin cortex, and is rescued by the intermediate filament network. Our study reveals a type of mechanical behaviour—which we term active superelasticity—that enables epithelial sheets to sustain extreme stretching under constant tension.

18 February 2019 in Nature Materials
Verified
Journal Article
Closed access
PDF file
EGElena Garreta
Elena Garreta
PPPatricia Prado
Patricia Prado
CTCarolina Tarantino
Carolina Tarantino
RORoger Oria
Roger Oria
LFLucia Fanlo
Lucia Fanlo
NMNuria Montserrat
Nuria Montserrat

1 May 2017 in Materials Today
Verified
Journal Article
Open access
EGElena Garreta
Elena Garreta
RORoger Oria
Roger Oria
CTCarolina Tarantino
Carolina Tarantino
MPMateu Pla-Roca
Mateu Pla-Roca
PPPatricia Prado
Patricia Prado
NMNuria Montserrat
Nuria Montserrat
Discarded human donor organs have been shown to provide decellularized extracellular matrix (dECM) scaffolds suitable for organ engineering. The quest for appropriate cell sources to satisfy the need of multiple cells types in order to fully repopulate human organ-derived dECM scaffolds has opened new venues for the use of human pluripotent stem cells (hPSCs) for recellularization. In addition, three-dimensional (3D) bioprinting techniques are advancing towards the fabrication of biomimetic cell-laden biomaterial constructs. Here, we review recent progress in decellularization/recellularization and 3D bioprinting technologies, aiming to fabricate autologous tissue grafts and organs with an impact in regenerative medicine

26 July 2011 in Stem Cells
Verified
Journal Article
Closed access
PDF file
CEC. Eguizabal
C. Eguizabal
NMN. Montserrat
N. Montserrat
RVRita Vassena
Rita Vassena
MBM. Barragan
M. Barragan
EGE. Garreta
E. Garreta
JBJ. C. Izpisua Belmonte
J. C. Izpisua Belmonte